Journal article
Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, Vol.69(3), pp.319-328
07/01/2015
DOI: 10.1097/QAI.0000000000000588
PMCID: PMC4506710
PMID: 25723140
Abstract
Objective:In resource-limited settings without safe alternatives to breastfeeding, the WHO recommends exclusive breastfeeding and antiretroviral (ARV) prophylaxis. Given the high prevalence of anemia among HIV-infected women, mothers and their infants (through fetal iron accretion) may be at risk of iron deficiency. We assessed the effects of maternal micronutrient-fortified lipid-based nutrient supplements (LNS) and maternal ARV treatment or infant ARV prophylaxis on maternal and infant iron status during exclusive breastfeeding from birth to 24 weeks.Methods:The Breastfeeding, Antiretrovirals, and Nutrition study was a randomized controlled trial conducted in Lilongwe, Malawi, from 2004 to 2010. HIV-infected mothers (CD4 >200 cells/L) and their infants were randomly assigned to 28-week interventions: maternal LNS/maternal ARV (n = 424), maternal LNS/infant ARV (n = 426), maternal LNS (n = 334), maternal ARV (n = 425), infant ARV (n = 426), or control (n = 334). Longitudinal models tested intervention effects on hemoglobin (Hb). In a subsample (n = 537) with multiple iron indicators, intervention effects on Hb, transferrin receptors (TfR), and ferritin were tested with linear and Poisson regression.Results:In longitudinal models, LNS effects on maternal and infant Hb were minimal. In subsample mothers, maternal ARVs were associated with tissue iron depletion (TfR >8.3 mg/L) (risk ratio: 3.1, P < 0.01), but not in ARV-treated mothers receiving LNS (P = 0.17). LNS without ARVs was not associated with iron deficiency or anemia (P > 0.1). In subsample infants, interventions were not associated with impaired iron status (all P > 0.1).Conclusions:Maternal ARV treatment with protease inhibitors is associated with maternal tissue iron depletion; but LNS mitigates adverse effects. ARVs do not seem to influence infant iron status; however, extended use needs to be evaluated.
Details
- Title: Subtitle
- Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding
- Creators
- Elizabeth M. Widen - University of North Carolina at Chapel HillMargaret E. Bentley - University of North Carolina at Chapel HillCharles S. Chasela - University of the WitwatersrandDumbani Kayira - UNC Project, Fac Hlth Sci, Lilongwe, MalawiValerie L. Flax - University of North Carolina at Chapel HillAthena P. Kourtis - Centers for Disease Control and PreventionSascha R. Ellington - Centers for Disease Control and PreventionZebrone Kacheche - UNC Project, Fac Hlth Sci, Lilongwe, MalawiGerald Tegha - UNC Project, Fac Hlth Sci, Lilongwe, MalawiDenise J. Jamieson - Centers for Disease Control and PreventionCharles M. van der Horst - University of North Carolina at Chapel HillLindsay H. Allen - Western Human Nutrition Research CenterSetareh Shahab-Ferdows - Western Human Nutrition Research CenterLinda S. Adair - University of North Carolina at Chapel HillBreastfeeding, Antiretrovirals and Nutrition (BAN) Study Team
- Resource Type
- Journal article
- Publication Details
- JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, Vol.69(3), pp.319-328
- DOI
- 10.1097/QAI.0000000000000588
- PMID
- 25723140
- PMCID
- PMC4506710
- NLM abbreviation
- J Acquir Immune Defic Syndr
- ISSN
- 1525-4135
- eISSN
- 2331-6993
- Publisher
- Lippincott Williams & Wilkins
- Number of pages
- 10
- Grant note
- GlaxoSmithKline Abbott Laboratories
- Language
- English
- Date published
- 07/01/2015
- Academic Unit
- Obstetrics and Gynecology; VPMA - Administration
- Record Identifier
- 9984446419302771
Metrics
19 Record Views